trial

nTMS for Negative Symptom in Schizophrenia

NCTId NCT06642675
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 40 (estimated)
Sponsored by Central South University
Primary completion 2026-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2024-11-22
Primary completion
2026-02
Eligibility
ALL · 60 Years

Interventions & indications

Drugs
Intermittent theta burst stimulation(iTBS)

Sponsors

Central South UniversityLead Sponsor

Investigators

1
Renrong Wu, M.D., Ph.D.Study Chair

Sites

1 total
Changsha, China

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2026-02
Status
RECRUITING
relationships
The graph out of here
drug
Intermittent theta burst stimulation(iTBS)
drug
lead_sponsor
Central South University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Renrong Wu, M.D., Ph.D.
person